Antimicrobial resistance (AMR) is a growing public health concern in the EU, which according to the
European Centre for Disease Prevention and Control (ECDC), is responsible for an estimated 33.000
deaths and €1.5 billion of added healthcare costs per year. One of the major global concerns in
today’s healthcare settings is the emergence and global spread of carbapenemase-producing
Enterobacterales (CPE). These are specific bacteria that are resistant to last resort antibiotics and
that spread easily in hospital settings, without appropriate Infection Prevention Control (IPC) policy.

The roundtable will offer a unique opportunity for AMR experts to share their latest findings
and best practices, which will enable both policymakers from the EU Institutions and national
representatives to have the essential information when they will discuss the upcoming EU policy
files on AMR and One Health.

The discussion will centre around the advantages that screening tools can bring in controlling the
silent spread of highly resistant micro-organism in hospitals. Through the lens of experts involved,
the event will consider how CPE screening can support Member States in improving IPC policy.